Search Results - "YANAI, Ayako"

Refine Results
  1. 1

    Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth by SAKAMOTO, Kei, MAEDA, Shin, HIKIBA, Yohko, NAKAGAWA, Hayato, HAYAKAWA, Yoku, SHIBATA, Wataru, YANAI, Ayako, OGURA, Keiji, OMATA, Masao

    Published in Clinical cancer research (01-04-2009)
    “…Purpose: Nuclear factor κB (NF-κB) is an important transcription factor in various biological processes. Constitutive NF-κB activation has been noted in many…”
    Get full text
    Journal Article
  2. 2

    A survey of antimicrobial resistance in Escherichia coli isolated from wild sika deer (Cervus nippon) in Japan by TAMAMURA-ANDOH, Yukino, TANAKA, Nobuyuki, SATO, Keisuke, MIZUNO, Yoshino, ARAI, Nobuo, WATANABE-YANAI, Ayako, AKIBA, Masato, KUSUMOTO, Masahiro

    “…We examined the antimicrobial susceptibility of 848 Escherichia coli isolates from 237 feces samples of wild sika deer (Cervus nippon) captured between 2016…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    C-Jun NH2-Terminal Kinase 1 Is a Critical Regulator for the Development of Gastric Cancer in Mice by SHIBATA, Wataru, MAEDA, Shin, HIKIBA, Yohko, YANAI, Ayako, SAKAMOTO, Kei, NAKAGAWA, Hayato, OGURA, Keiji, KARIN, Michael, OMATA, Masao

    Published in Cancer research (Chicago, Ill.) (01-07-2008)
    “…c-Jun NH(2)-terminal kinase (JNK) links several cellular processes, including proliferation and survival, and is believed to be involved in carcinogenesis…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer by Maeda, Shin, Hikiba, Yohko, Shibata, Wataru, Ohmae, Tomoya, Yanai, Ayako, Ogura, Keiji, Yamada, Shingo, Omata, Masao

    “…High-mobility group box 1 (HMGB1) is a nuclear factor released extracellularly as a proinflammatory cytokine. We measured the HMGB1 concentration in the sera…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The Effect of Helicobacter pylori Eradication on Reducing the Incidence of Gastric Cancer by Ogura, Keiji, Hirata, Yoshihiro, Yanai, Ayako, Shibata, Wataru, Ohmae, Tomoya, Mitsuno, Yuzo, Maeda, Shin, Watabe, Hirotsugu, Yamaji, Yutaka, Okamoto, Makoto, Yoshida, Haruhiko, Kawabe, Takao, Omata, Masao

    Published in Journal of clinical gastroenterology (01-03-2008)
    “…Epidemiologically, the association between chronic Helicobacter pylori infection and development of gastric cancer is well established. Although the…”
    Get full text
    Journal Article
  12. 12

    Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases by Nishimukai, Arisa, Higuchi, Tomoko, Ozawa, Hiromi, Yanai, Ayako, Miyagawa, Yoshimasa, Murase, Keiko, Imamura, Michiko, Takatsuka, Yuichi, Miyoshi, Yasuo

    Published in Breast cancer (Tokyo, Japan) (01-03-2017)
    “…Background Bone-modifying agents are effective for treatment of breast cancer patients with bone metastases. Since their action is mediated through suppression…”
    Get full text
    Journal Article
  13. 13

    Effectiveness of IκB kinase inhibitors in murine colitis-associated tumorigenesis by Hayakawa, Yoku, Maeda, Shin, Nakagawa, Hayato, Hikiba, Yohko, Shibata, Wataru, Sakamoto, Kei, Yanai, Ayako, Hirata, Yoshihiro, Ogura, Keiji, Muto, Susumu, Itai, Akiko, Omata, Masao

    Published in Journal of gastroenterology (01-09-2009)
    “…Purpose Nuclear factor κB (NF-κB) activation is involved in various inflammatory illnesses, for example inflammatory bowel disease, and is thought to be a key…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients by Sakitani, Kosuke, Hirata, Yoshihiro, Suzuki, Nobumi, Shichijo, Satoki, Yanai, Ayako, Serizawa, Takako, Sakamoto, Kei, Akanuma, Masao, Maeda, Shin, Yamaji, Yutaka, Iwamoto, Yasuhiko, Kawazu, Shoji, Koike, Kazuhiko

    Published in BMC gastroenterology (21-10-2015)
    “…Helicobacter pylori infection is the most important risk factor for gastric cancer, for which eradication therapy is commonly performed. However, gastric…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes by Higuchi, Tomoko, Nishimukai, Arisa, Ozawa, Hiromi, Fujimoto, Yukie, Yanai, Ayako, Miyagawa, Yoshimasa, Murase, Keiko, Imamura, Michiko, Takatsuka, Yuichi, Kitajima, Kazuhiro, Fukushima, Kazuhito, Miyoshi, Yasuo

    Published in Breast (Edinburgh) (01-12-2016)
    “…Adjuvant treatments for operable breast cancers are determined according to subtypes defined based on estrogen receptor (ER) and human epidermal growth factor…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Influence of Helicobacter pylori eradication on the management of type 2 diabetes by Akanuma, Masao, Yanai, Ayako, Sakamoto, Kei, Hirata, Yoshihiro, Yamaji, Yutaka, Kawazu, Shoji, Maeda, Shin

    Published in Hepato-gastroenterology (01-03-2012)
    “…H. pylori eradication therapy has been widely performed. In addition, the number of patients with type 2 diabetes is increasing worldwide. The aim of this…”
    Get more information
    Journal Article